| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 24, 2006
Accepted on January 8, 2007
Dept. of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030
* To whom correspondence should be addressed. E-mail: jwong{at}bcm.tmc.
Androgen receptor (AR), a member of the nuclear receptor superfamily, is a modular protein comprised of a N-terminal domain (NTD), a central DNA binding domain (DBD) and a C-terminal ligand-binding domain (LBD). Previous structural and functional studies have shown that deletion of the LBD generates an AR molecule with full transcriptional activity in many transient transfection assays. In this study we show that deletion of either the NTD1–478 (AR
N) or LBD680–919 (AR
C) cripples AR transcriptional activity in chromatin. Both AR
N and AR
C mutants are impaired in binding to target genes in chromatin. Overexpression of SRC-1 coactivator partially rescued transcriptional and chromatin-binding defects of AR
N and AR
C mutants. Expression of SRC-1 also enhances the binding of the wild-type AR to chromatin, thus revealing a role of SRC-1 in promoting binding of AR to chromatin. We also demonstrate that expression of the AR NTD1–501 in trans can substantially rescue the chromatin binding, but not the transcriptional defect of AR
N, indicating that binding of AR to chromatin is a step separable from AR induced transcriptional activation. Finally we present evidence that, in contrast to transient transfection, AR NTD alone cannot efficiently activate transcription in chromatin.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |